IL6 and COVID-19: This was consistent with a proteomics study comparing differences in COVID-19 and bacterial acute respiratory distress syndrome (ARDS; often accompanies sepsis), which found that proteins involved in IL6-JAK-STAT3 signaling were elevated in COVID-19 (52).